SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-23-000056
Filing Date
2023-08-07
Accepted
2023-08-07 17:16:32
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20230630.htm   iXBRL 10-Q 644470
2 EX-31.1 mlys-2q2310qex311.htm EX-31.1 9814
3 EX-31.2 mlys-2q2310qex312.htm EX-31.2 9751
4 EX-32.1 mlys-2q2310qex321.htm EX-32.1 5050
5 EX-32.2 mlys-2q2310qex322.htm EX-32.2 4954
  Complete submission text file 0001933414-23-000056.txt   3645965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20230630.xsd EX-101.SCH 24726
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20230630_cal.xml EX-101.CAL 32277
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20230630_def.xml EX-101.DEF 155225
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20230630_lab.xml EX-101.LAB 397123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20230630_pre.xml EX-101.PRE 265253
47 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20230630_htm.xml XML 324726
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 231148522
SIC: 2834 Pharmaceutical Preparations